Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 7
Submit an article Journal homepage
683
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Thrombocytopenia in patients with myelofibrosis: management options in the era of JAK inhibitor therapy

Giulia BenevoloHematology, AOU Città della Salute e della Scienza, Turin, Italy; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3200-9654
ORCID Icon,
Elena M. ElliHematology Division and Bone Marrow Unit, San Gerardo Hospital, Monza, Italy;
,
Paola GuglielmelliCRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Department of Experimental and Clinical Medicine, Azienda ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy;
,
Alessandra RiccoDepartment of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, University of Bari, Bari, Italy;
&
Margherita MaffioliHematology, Department of Medicine and Surgery, University of Insubria, Varese, Italy
Pages 1535-1547 | Received 18 Nov 2019, Accepted 03 Feb 2020, Published online: 24 Feb 2020

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Pankit Vachhani, Srdan Verstovsek & Prithviraj Bose. (2023) Cytopenic myelofibrosis: prevalence, relevance, and treatment. Expert Opinion on Pharmacotherapy 24:8, pages 901-912.
Read now

Articles from other publishers (4)

Srdan Verstovsek, Ruben A. Mesa, Robert A. Livingston, Wilson Hu & John Mascarenhas. (2023) Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety. Journal of Hematology & Oncology 16:1.
Crossref
Jona F. Houthuys, Alexander P. Wilmer, Marijke Peetermans, Philippe Meersseman & Timothy Devos. (2022) Severe ARDS due to Ruxolitinib discontinuation syndrome: case presentation and literature review. Heliyon 8:12, pages e11782.
Crossref
Dahniel Sastow, John Mascarenhas & Douglas Tremblay. (2022) Thrombocytopenia in Patients With Myelofibrosis: Pathogenesis, Prevalence, Prognostic Impact, and Treatment. Clinical Lymphoma Myeloma and Leukemia 22:7, pages e507-e520.
Crossref
Ronda Copher, Arianna Kee & Aaron Gerds. (2022) Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United States. The Oncologist 27:3, pages 228-235.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.